Creative Medical Technology Receives FDA Clearance To Expand Its ADAPT Clinical Trial Evaluating CELZ-201 For Chronic Lower Back Pain Associated With Degenerative Disc Disease

뉴스 본문을 불러오고 있어요.

Creative Medical Technology Receives FDA Clearance To Expand Its ADAPT Clinical Trial Evaluating CELZ-201 For Chronic Lower Back Pain Associated With Degenerative Disc Disease | 웨이프 WAPE

Creative Medical Technology Receives FDA Clearance To Expand Its ADAPT Clinical Trial Evaluating CELZ-201 For Chronic Lower Back Pain Associated With Degenerative Disc Disease

기사 요약

관련 종목

댓글 —